John Olszewski

Array ( [id] => 14762445 [patent_doc_number] => 10392610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-27 [patent_title] => Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides [patent_app_type] => utility [patent_app_number] => 14/466055 [patent_app_country] => US [patent_app_date] => 2014-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22683 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11004079 [patent_doc_number] => 20160201028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING a-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/913312 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16849 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10250349 [patent_doc_number] => 20150135345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'Rationally Designed Meganucleases With Altered Sequence Specificity and DNA-Binding Affinity' [patent_app_type] => utility [patent_app_number] => 14/463059 [patent_app_country] => US [patent_app_date] => 2014-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26571 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14463059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822446 [patent_doc_number] => 20160168610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'METHODS FOR BIOSYNTHESIZING 3-OXOPENT-4-ENOYL-CoA' [patent_app_type] => utility [patent_app_number] => 14/908659 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7292 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001700 [patent_doc_number] => 09045779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Increased ethanol production by genetic engineering of microorganisms to express hemoglobin' [patent_app_type] => utility [patent_app_number] => 14/340129 [patent_app_country] => US [patent_app_date] => 2014-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 10323 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529131 [patent_doc_number] => 09255260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Cytotoxic ribonuclease variants' [patent_app_type] => utility [patent_app_number] => 14/335386 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7874 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925952 [patent_doc_number] => 20140328972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Xylanases for Animal Feed' [patent_app_type] => utility [patent_app_number] => 14/335245 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11640 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822440 [patent_doc_number] => 20160168605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'A NOVEL MODIFIED ORNITHINE DECARBOXYLASE PROTEIN AND A USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/905793 [patent_app_country] => US [patent_app_date] => 2014-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8790 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12509985 [patent_doc_number] => 10000782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Recombinant host cell for the biosynthesis of vanillin or vanillin beta-D-glucoside [patent_app_type] => utility [patent_app_number] => 14/905228 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10440 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281987 [patent_doc_number] => 20150166984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'METHODS FOR CORRECTING ALPHA-ANTITRYPSIN POINT MUTATIONS' [patent_app_type] => utility [patent_app_number] => 14/326290 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18807 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791843 [patent_doc_number] => 20160137998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'Subtilase Variants and Polynucleotides Encoding Same' [patent_app_type] => utility [patent_app_number] => 14/899583 [patent_app_country] => US [patent_app_date] => 2014-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44493 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12099372 [patent_doc_number] => 09856460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Nucleic acids encoding synthetic scaffolds and host cells genetically modified with the nucleic acids' [patent_app_type] => utility [patent_app_number] => 14/315102 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 23615 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983405 [patent_doc_number] => 09029112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Ketoreductase-mediated stereoselective route to alpha chloroalcohols' [patent_app_type] => utility [patent_app_number] => 14/313465 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36389 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14313465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9798580 [patent_doc_number] => 20150010523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHOD FOR TREATING SYSTEMIC DNA MUTATION DISEASE' [patent_app_type] => utility [patent_app_number] => 14/309363 [patent_app_country] => US [patent_app_date] => 2014-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10762244 [patent_doc_number] => 20160108387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'NOVEL METALLOPROTEASES' [patent_app_type] => utility [patent_app_number] => 14/893440 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 163391 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10255638 [patent_doc_number] => 20150140636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'POLYNUCLEOTIDES ENCODING MUTANT HYDROLASE PROTEINS WITH ENHANCED KINETICS AND FUNCTIONAL EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/285327 [patent_app_country] => US [patent_app_date] => 2014-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 29905 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13065857 [patent_doc_number] => 10053703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Heterologous production of patchoulol, b-santalene, and sclareol in moss cells [patent_app_type] => utility [patent_app_number] => 14/901320 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12835 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11212184 [patent_doc_number] => 09441213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Constructs and methods for the production and secretion of polypeptides' [patent_app_type] => utility [patent_app_number] => 14/249065 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634811 [patent_doc_number] => 20140212920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'MUTANT GAMMA-GLUTAMYLTRANSFERASE, AND A METHOD FOR PRODUCING GAMMA-GLUTAMYLVALYLGLYCINE OR A SALT THEREOF' [patent_app_type] => utility [patent_app_number] => 14/243458 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14630 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14243458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9671054 [patent_doc_number] => 20140234916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'METHOD FOR PRODUCING MONATIN USING AN L-AMINO ACID AMINOTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 14/230766 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 39157 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14230766 [rel_patent_id] =>[rel_patent_doc_number] =>)